impact mill / rotor / laboratory / for the pharmaceutical industry
laboratory, for the pharmaceutical industry, R&D
GRANUMILL size reduction systems meet FDA SUPAC (Scale-Up and Post-Approval Changes) guidelines for both impact and screening mills, allowing for low-RPM screening of agglomerates in addition to high-speed impact milling. The mill’s versatile design combined with the new, removable containment option provides users with the flexibility to run a variety of processes for a range of applications on a single, cost-effective system.
R&D or laboratory-scale units provide effective size reduction or de-agglomeration for small batches.